~60% of individuals are nonadherent—learn about the outcomes, key dimensions, and ways adherence is measured in this downloadable infographic. Read More
This educational infographic is designed to raise awareness among healthcare providers about the potential role of the Norepinephrine, Serotonin, and Dopamine (NSD) neurotransmitter systems in Alzheimer’s-related agitation. Read More
In March 2023, we launched a survey of PsychU members to assess the stigma associated with AAD. This infographic summarizes the results of the survey. Over a 30-day period, 194… Read More
Explore with us, the barriers to treatment access and challenges faced by the medical community in delivering equitable care to agitated individuals with Alzheimer’s Disease from diverse backgrounds. Read More
Join us for a PsychU on-demand webinar exploring unresolved symptoms in major depressive disorder (MDD) and the potential role of norepinephrine, as part of the monoaminergic theory of depression. Read More
This presentation introduces the improved coding options, and describes the coding structure format used in the updated dementia code sections. New code guidance for agitation in Alzheimer’s dementia is compared… Read More
Dive into our PsychU resources! This collaborative infographic with NephU reviews some of the findings of racial and ethnic diversity and socioeconomic impart in clinical trials. Read More
In this Faces of Depression webinar, Dr. Beth DiNapoli moderates an enlightening discussion on various presentations of depression across the adult lifespan with primary care physician and clinical researcher Dr.… Read More
Join us in this webinar as our panelists discuss their experiences on preparing for a mental health crisis, share their perspectives on implementation and utility of 988, impact on emergency… Read More